Global pharmaceutical company required centralized monitoring and fraud detection to strengthen compliance
A global pharmaceutical company was struggling with inconsistent monitoring of travel and entertainment (T&E) expenses across regions. The company’s global operations meant that T&E expenses were managed differently across regions and lacked standardized controls, resulting in:
When the company approached us, we knew that without a centralized approach, the compliance team struggled to identify both known fraud risks and emerging patterns of suspicious behavior.
To address these challenges, konaAI tailored the monitoring rules to each region while centralizing oversight, offering the company greater control without increasing manual effort.
How a Fortune 100 company operating in 190 countries uncovered ~$75 million in potential cost…
The DOJ now expects compliance to evaluate culture, not just monitor it. Most CCOs aren’t…
Fraudsters are already using generative AI to forge receipts, invoices, contracts, even I-9s. Fighting back…
Manual bid reviews rely on random sampling, which means the risk that matters most can…
Refund fraud, discount abuse, and inventory manipulation quietly drain margins that manual reviews miss.
How a Fortune 100 Leader Uncovered ~$75 million in Potential Excess Payments to Vendors
This website uses cookies.